White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.


BACKGROUND AND PURPOSE White matter lesion (WML) progression has been advocated as a surrogate marker in intervention trials on cerebral small vessel disease. We assessed the rate of visually rated WML progression, studied correlations between lesion progression and cognition, and estimated sample sizes for clinical trials with pure WML progression vs… (More)

3 Figures and Tables


  • Presentations referencing similar topics